Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35179
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOw, Connie P C-
dc.contributor.authorOkazaki, Nobuki-
dc.contributor.authorIguchi, Naoya-
dc.contributor.authorPeiris, Rachel M-
dc.contributor.authorEvans, Roger G-
dc.contributor.authorHood, Sally G-
dc.contributor.authorMay, Clive N-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorLankadeva, Yugeesh R-
dc.date2024-
dc.date.accessioned2024-04-02T01:57:46Z-
dc.date.available2024-04-02T01:57:46Z-
dc.date.issued2024-03-29-
dc.identifier.citationExperimental Physiology 2024-03-29en_US
dc.identifier.issn1469-445X-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35179-
dc.description.abstractIt has been proposed that diuretics can improve renal tissue oxygenation through inhibition of tubular sodium reabsorption and reduced metabolic demand. However, the impact of clinically used diuretic drugs on the renal cortical and medullary microcirculation is unclear. Therefore, we examined the effects of three commonly used diuretics, at clinically relevant doses, on renal cortical and medullary perfusion and oxygenation in non-anaesthetised healthy sheep. Merino ewes received acetazolamide (250 mg; n = 9), furosemide (20 mg; n = 10) or amiloride (10 mg; n = 7) intravenously. Systemic and renal haemodynamics, renal cortical and medullary tissue perfusion and PO2${P_{{{\mathrm{O}}_{\mathrm{2}}}}}$ , and renal function were then monitored for up to 8 h post-treatment. The peak diuretic response occurred 2 h (99.4 ± 14.8 mL/h) after acetazolamide, at which stage cortical and medullary tissue perfusion and PO2${P_{{{\mathrm{O}}_{\mathrm{2}}}}}$ were not significantly different from their baseline levels. The peak diuretic response to furosemide occurred at 1 h (196.5 ± 12.3 mL/h) post-treatment but there were no significant changes in cortical and medullary tissue oxygenation during this period. However, cortical tissue PO2${P_{{{\mathrm{O}}_{\mathrm{2}}}}}$ fell from 40.1 ± 3.8 mmHg at baseline to 17.2 ± 4.4 mmHg at 3 h and to 20.5 ± 5.3 mmHg at 6 h after furosemide administration. Amiloride did not produce a diuretic response and was not associated with significant changes in cortical or medullary tissue oxygenation. In conclusion, clinically relevant doses of diuretic agents did not improve regional renal tissue oxygenation in healthy animals during the 8 h experimentation period. On the contrary, rebound renal cortical hypoxia may develop after dissipation of furosemide-induced diuresis.en_US
dc.language.isoeng-
dc.subjectacetazolamideen_US
dc.subjectamilorideen_US
dc.subjectfurosemideen_US
dc.subjecthypoxiaen_US
dc.subjectrenal oxygenationen_US
dc.titleEffects of furosemide, acetazolamide and amiloride on renal cortical and medullary tissue oxygenation in non-anaesthetised healthy sheep.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleExperimental Physiologyen_US
dc.identifier.affiliationPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Anesthesiology and Resuscitology, Okayama University, Okayama, Japan.en_US
dc.identifier.affiliationDepartment of Anesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.en_US
dc.identifier.affiliationCardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.;Department of Intensive Care, Austin Hospital, Melbourne, Australia.;Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationPreclinical Critical Care Unit, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.;Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationData Analytics Research and Evaluation (DARE) Centreen_US
dc.identifier.doi10.1113/EP091479en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-5402-1809en_US
dc.identifier.pubmedid38551893-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

58
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.